neobookRx
GuidelinesIMCI

ARV Prophylaxis: Nevirapine (NVP) and Zidovudine (AZT) (Birth up to 2 months)

IMCI - Young Infant (Birth up to 2 months)

Give ARV Prophylaxis

Risk Category Scenario Infant ART prophylaxis
LOW RISK (at birth) Newborn infant of mother on ART with a VL result of <1000 copies/ ml at delivery Nevirapine (NVP) for 6 weeks
HIGH RISK (at birth)

At birth:

• Mother on ART with a VL of >1000 copies/ ml at delivery or no HIV VL available at birth/ within the last 12 weeks before birth

• Mother not on ART at delivery

Nevirapine (NVP) for at least 12 weeks, until mother’s VL is <1000 copies/ ml or until 1 week after cessation of all breastfeeding

AND

Zidovudine (AZT) for 6 weeks

HIGH RISK (during breastfeeding)

During breastfeeding:

• Mother on ART with latest VL of >1000 copies/ ml

• Mother not on ART

Nevirapine (NVP) for at least 12 weeks, until mother’s VL is <1000 copies/ ml or until 1 week after cessation of all breastfeeding

AND

Zidovudine (AZT) for 6 weeks

HIGH RISK (exclusive formula feeding)

Exclusively formula fed infant of:

• Mother not on ART at delivery

• Mother on ART with VL >1000 copies/ ml at delivery or no HIV VL at birth/ with the last 12 weeks before birth

Nevirapine (NVP) for 6 weeks

AND

Zidovudine (AZT) for 6 weeks

If at any stage the infant’s PCR test is positive, stop prophylaxis and initiate ART according to the six steps 

Obtain expert advice on dosing of NVP and AZT for:

  • Premature infants <35 weeks gestation and <2.0 kg
  • Infants underweight for age (with WFA z-score < -3)

Nevirapine (NVP)

Age  NEVIRAPINE (NVP) SOLUTION (10mg/ml) Once daily
Birth to 6 weeks

Weight 2.0 - < 2.5 kg: 1 ml (10mg) daily

Weight 2.5 kg or more: 1.5 ml (15mg) daily

6 weeks up to 6 months 2 ml (20mg) daily
6 months up to 9 months 3 ml (30mg) daily
9 months until 1 week after breastfeeding stops 4 ml (40mg) daily

Zidovudine (AZT)

Age  ZIDOVUDINE (AZT) SOLUTION (10mg/ml) Twice daily
Birth to 6 weeks

Weight 2.0 - < 2.5kg kg: 1 ml (10 mg) twice daily

Weight 2.5 kg: 1.5 ml (15 mg) twice daily

> 6 weeks

Weight 3.0 - < 6 kg: 6 ml (60 mg) twice daily

Weight 6 - 8 kg: 9 ml (90 mg) twice daily

Click here to open the above content in the original PDF view


Integrated Management of Childhood Illness 2022; Young Infant (Birth up to 2 months); Treat the Young Infant: Give ARV Prophylaxis: Nevirapine (NVP),  Zidovudine (AZT).


Last checked for updates: June 2023

Drugs mentioned

NeoHealth® ID 19800 · updated 8/21/2023